Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2012, Article ID 542042, 7 pages
http://dx.doi.org/10.1155/2012/542042
Research Article

Sodium-Glucose Cotransporter Inhibition Prevents Oxidative Stress in the Kidney of Diabetic Rats

1Renal Pathophysiology Laboratory, Department of Nephrology, Instituto Nacional de Cardiología “Ignacio Chávez”, Juan Badiano 1, 14080 Mexico City, DF, Mexico
2Health Science Faculty, Universidad Anáhuac, México Norte, 57286 Huixquilucan, State of Mexico, Mexico
3Department of Molecular Biomedicine, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), 07360 Mexico City, Mexico
4Department of Molecular Biomedicine, CINVESTAV-Monterrey, 66600 Apodaca, NL, Mexico

Received 7 June 2012; Accepted 13 October 2012

Academic Editor: José Luis Martín-Ventura

Copyright © 2012 Horacio Osorio et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Shamoon, H. Duffy, N. Fleischer et al., “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus,” New England Journal of Medicine, vol. 329, no. 14, pp. 977–986, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. S. P. Bagby, “Diabetic nephropathy and proximal tubule ROS: challenging our glomerulocentricity,” Kidney International, vol. 71, no. 12, pp. 1199–1202, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Vallon, “The proximal tubule in the pathophysiology of the diabetic kidney,” The American Journal of Physiology, vol. 300, no. 5, pp. R1009–R1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. C. Garg, S. Ojha, and D. D. Bansal, “Antioxidant status of streptozotocin diabetic rats,” Indian Journal of Experimental Biology, vol. 34, no. 3, pp. 264–266, 1996. View at Google Scholar · View at Scopus
  5. H. Ha and H. B. Lee, “Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney,” Nephrology, vol. 10, supplement 2, pp. S7–S10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Osorio, R. Bautista, A. Rios, M. Franco, J. Santamaría, and B. Escalante, “Effect of treatment with losartan on salt sensitivity and SGLT2 expression in hypertensive diabetic rats,” Diabetes Research and Clinical Practice, vol. 86, no. 3, pp. e46–e49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Osorio, R. Bautista, A. Rios et al., “Effect of phlorizin on SGLT2 expression in the kidney of diabetic rats,” Journal of Nephrology, vol. 23, no. 5, pp. 541–546, 2010. View at Google Scholar · View at Scopus
  8. H. Osorio, I. Coronel, A. Arellano, M. Franco, B. Escalante, and R. Bautista, “Ursodeoxycholic acid decreases sodium-glucose cotransporter (SGLT2) expression and oxidative stress in the kidney of diabetic rats,” Diabetes Research and Clinical Practice, vol. 97, no. 2, pp. 276–282, 2012. View at Google Scholar
  9. T. Asano, M. Anai, H. Sakoda et al., “SGLT as a therapeutic target,” Drugs of the Future, vol. 29, no. 5, pp. 461–466, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. L. Handlon, “Sodium glucose co-transporter 2 (SGLT2) inhibitors as potential antidiabetic agents,” Expert Opinion on Therapeutic Patents, vol. 15, no. 11, pp. 1531–1540, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. S. W. Janssen, G. J. Martens, C. G. Sweep, P. N. Span, A. A. J. Verhofstad, and A. R. M. M. Hermus, “Phlorizin treatment prevents the decrease in plasma insulin levels but not the progressive histopathological changes in the pancreatic islets during aging of Zucker diabetic fatty rats,” Journal of Endocrinological Investigation, vol. 26, no. 6, pp. 508–515, 2003. View at Google Scholar · View at Scopus
  12. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Google Scholar · View at Scopus
  13. H. Aebi, “Catalase in vitro,” Methods in Enzymology, vol. 105, pp. 121–126, 1984. View at Publisher · View at Google Scholar · View at Scopus
  14. R. A. Lawrence and R. F. Burk, “Glutathione peroxidase activity in selenium deficient rat liver,” Biochemical and Biophysical Research Communications, vol. 71, no. 4, pp. 952–958, 1976. View at Google Scholar · View at Scopus
  15. Y. Sun, L. W. Oberley, and Y. Li, “A simple method for clinical assay of superoxide dismutase,” Clinical Chemistry, vol. 34, no. 3, pp. 497–500, 1988. View at Google Scholar · View at Scopus
  16. M. Brownlee, “Biochemistry and molecular cell biology of diabetic complications,” Nature, vol. 414, no. 6865, pp. 813–820, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Ha and K. H. Kim, “Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C,” Diabetes Research and Clinical Practice, vol. 45, no. 2-3, pp. 147–151, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. R. E. Gilbert and M. E. Cooper, “The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?” Kidney International, vol. 56, no. 5, pp. 1627–1637, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Bank and H. S. Aynedjian, “Progressive increases in luminal glucose stimulate proximal sodium absorption in normal and diabetic rats,” Journal of Clinical Investigation, vol. 86, no. 1, pp. 309–316, 1990. View at Google Scholar · View at Scopus
  20. W. T. Noonan, V. M. Shapiro, and R. O. Banks, “Renal glucose reabsorption during hypertonic glucose infusion in female streptozotocin-induced diabetic rats,” Life Sciences, vol. 68, no. 26, pp. 2967–2977, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. L. A. Sechi, A. Ceriello, C. A. Griffin et al., “Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus,” Diabetologia, vol. 40, no. 1, pp. 23–29, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Horie, T. Miyata, K. Maeda et al., “Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy,” Journal of Clinical Investigation, vol. 100, no. 12, pp. 2995–3004, 1997. View at Google Scholar · View at Scopus
  23. H. Ha, C. Kim, Y. Son, M. H. Chung, and K. H. Kim, “DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria,” Free Radical Biology and Medicine, vol. 16, no. 2, pp. 271–274, 1994. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Halliwell, “What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo,” FEBS Letters, vol. 411, no. 2-3, pp. 157–160, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Pacher, I. Obrosova, J. Mabley, and C. Szabó, “Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications: emerging new therapeutical strategies,” Current Medicinal Chemistry, vol. 12, no. 3, pp. 267–275, 2005. View at Google Scholar · View at Scopus
  26. N. Ishii, K. P. Patel, P. H. Lane et al., “Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus,” Journal of the American Society of Nephrology, vol. 12, no. 8, pp. 1630–1639, 2001. View at Google Scholar · View at Scopus
  27. M. L. Onozato, A. Tojo, A. Goto, T. Fujita, and C. S. Wilcox, “Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB,” Kidney International, vol. 61, no. 1, pp. 186–194, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. R. C. Thuraisingham, C. A. Nott, S. M. Dodd, and M. M. Yaqoob, “Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy,” Kidney International, vol. 57, no. 5, pp. 1968–1972, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Malatiali, I. Francis, and N. M. Barac, “Phlorizin prevents glomerular hyperfiltration but not hypertrophy in diabetic rats,” Experimental Diabetes Research, vol. 2008, Article ID 305403, 7 pages, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Adachi, K. Yasuda, Y. Okamoto et al., “T-1095, A renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats,” Metabolism, vol. 49, no. 8, pp. 990–995, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Oku, K. Ueta, K. Arakawa et al., “T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes,” Diabetes, vol. 48, no. 9, pp. 1794–1800, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Arakawa, T. Ishihara, A. Oku et al., “Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na+-glucose cotransporter inhibitor T-1095,” British Journal of Pharmacology, vol. 132, no. 2, pp. 578–586, 2001. View at Google Scholar · View at Scopus